October 17, 2019

October 16, 2019

Subscribe to Latest Legal News and Analysis

October 15, 2019

Subscribe to Latest Legal News and Analysis

October 14, 2019

Subscribe to Latest Legal News and Analysis

Pleading Standard Defined– Federal Circuit Holds Joint Infringement Complaint Requires Identification of All Required Claim Steps

Plaintiffs bringing patent infringement complaints under the Iqbal/Twombly pleading standard should take notice.  On September 30, 2016, a panel of the Federal Circuit affirmed a district court’s dismissal of a deficient complaint under Rule 12(b)(6).  The panel agreed held that a complaint for joint infringement of a patent must show which alleged actor performed each of the required claim elements.  The plaintiff’s amended complaint failed to plausibly allege that the defendants exercised the required “direction or control” such that the performance of every claim step could be attributable to them.

The plaintiff, Edwin Lyda, brought a complaint against CBS Corporation and its subsidiary CBS Interactive, Inc. (“CBS”) for infringement of claims of U.S. Patent Nos. 7,434,243 and 7,730,506. The patents cover methods and systems for “obtaining real time responses to remote programming by allowing persons viewing or listening to a broadcast to respond to the broadcast in real time without requiring a personal computer.” Lyda alleged that CBS infringed claims of the patents for producing and operating the television show “Big Brother.”  After CBS informed Mr. Lyda of alleged deficiencies in the original complaint, Mr. Lyda filed an amended complaint alleging that CBS infringed Mr. Lyda’s patents by allowing television audience members to provide feedback about the show by voting via text message on their cellular phones. The district court for the Southern District of New York granted CBS’ motion to dismiss and denied Mr. Lyda’s motion for leave to file a second amended complaint.

The Federal Circuit affirmed and rejected Mr. Lyda’s position that the amended complaint should be measured against the Form 18 pleading standard.  While the panel agreed that the repeal of Form 18 did not apply based on the filing date of the amended complaint, it nevertheless applied the Iqbal/Twombly pleading standard because of the nature of the joint infringement counts. The panel agreed with previous district court holdings concluding that allegations of joint infringement cannot be satisfied by Form 18.  Citing to its prior decision in Akamai Techs., Inc. v. Limelight Networks, Inc., 797 F.3d 1020, 1022 (Fed. Cir. 2015) (en banc) and applying Iqbal/Twombly, the panel held that to survive a motion to dismiss the Amended Complaint needed to plausibly allege that the Defendants exercised the requisite “direction or control” over the performance of the claim steps, such that performance of every step is attributable to Defendants.  The plaintiff failed to do so:

Rather, the Amended Complaint alleges conclusively and without factual support that CBS directed or controlled the independent contractors who then directed or controlled the unnamed third parties. There are thus no allegations in the Amended Complaint that can form the basis of a reasonable inference that each claim step was performed by or should be attributed to Defendants.

In its decision, the panel noted that even “a typical claim of direct infringement requires proof that a defendant performs each step of the claimed method.”  Given that Form 18 is no longer in use, the case suggests that plaintiffs in any patent infringement action will need to provide facts showing that every claim element has been met.

©1994-2019 Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. All Rights Reserved.


About this Author

Adam Samansky, Mintz Levin Law Firm, Boston, Patent Litigation Attorney

Adam’s practice focuses on intellectual property litigation. He handles patent, trademark, and trade secret matters on behalf of innovators and investors in a range of industries. His core practice includes patent and trade secret litigation involving complex technologies in the pharmaceutical, medical, high-tech, and defense industries. Adam has tried cases before multiple US District Courts, briefed and argued cases before the US Court of Appeals for the Federal Circuit, and has briefed bet-the-company issues before the US Supreme Court.

Peter J. Cuomo, Mintz Levin, Patent Litigation Lawyer, Expert Discovery Attorney,Patent Litigation IPRs & Other Post-Grant Proceedings Federal Circuit Appeals Hatch-Waxman ,ANDA Litigation Federal District Court
Of Counsel

Peter’s practice involves intellectual property enforcement and defense, and client counseling on issues related to IP rights. Peter's primary focus is in patent litigation where he has experience in every phase from pre-suit investigations through appeal, including, initial evaluation and case initiation, fact and expert discovery, pre-and post-trial motion practice, and trials and appeals. In addition to suits centered on the assertion and defense of infringement claims, Peter has experience with the successful resolution of multiple inventorship disputes and related misappropriation claims.

Peter has represented clients across a wide range of technologies such as biotechnology inventions, automotive parts, medical and mechanical devices, consumer products. He has also worked on numerous high-stakes Hatch-Waxman litigations for major pharmaceutical companies through trial and appeals. In addition to patent litigation, Peter has experience in disputes involving breach of contracts, unfair competition, trademarks and trade secret misappropriation claims.

Peter is a registered patent attorney licensed to practice and argue before the United States Patent and Trademark Office. In addition to representing clients in US District Courts and the US Court of Appeals for the Federal Circuit, he has experience in multiple post-grant proceedings before the Patent Trial and Appeal Board and its predecessor. He also provides patent and product analyses, and evaluations of prior art related to infringement and invalidity opinions.

Prior to joining the firm, he practiced in the intellectual property litigation practice in the Boston office of another international law firm. Peter also previously worked in and supervised an academic laboratory focused on researching infectious diseases. He is a co-author on multiple scientific papers and spent time in Zambia investigating the co-infection of measles and HIV. During law school, Peter was an editor on the Boston University Journal of Science and Technology Law and worked as a research assistant in intellectual property and the Health Law Department.